{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:15:04Z","timestamp":1790190904797,"version":"4.1.0"},"reference-count":23,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.21","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T23:26:52Z","timestamp":1371770812000},"page":"21-28","source":"Crossref","is-referenced-by-count":8,"title":["A Case of Extramedullary Plasmablastic Plasmacytoma Successfully Treated Using a Combination of Thalidomide and Dexamethasone and a Review of the Medical Literature"],"prefix":"10.3960","volume":"53","author":[{"given":"Yasunobu","family":"Sekiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taito","family":"Asahina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fujii R, Ishikawa H, Mahmoud MS, Asaoku H, Kawano MM: MPC-1<SUP>-<\/SUP>CD49e<SUP>-<\/SUP> immature myeloma cells include CD45<SUP>+<\/SUP> subpopulations that can proliferate in response to IL-6 in human myelomas. Br J Haematol 105:131-140, 1999","DOI":"10.1111\/j.1365-2141.1999.01281.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Greipp PR, Raymond NM, Kyle RA, O'Fallon WM: Multiple myeloma : Significance of plasmablastic subtype in morphological classification. Blood 65:305-310, 1985","DOI":"10.1182\/blood.V65.2.305.bloodjournal652305"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Okikawa Y, Sakai A, Takimoto Y, Noda M, Imagawa J, <I>et al<\/I>.: Progressive myeloma after thalidomide therapy in a patient with immature phenotype of myeloma (plasma) cells. Int J Hematol 79:364-368, 2004","DOI":"10.1532\/IJH97.04005"},{"key":"4","unstructured":"4 Rosi&#241;ol L, Cibeira MT, Blad&eacute; J, Esteve J, Aymerich M, <I>et al<\/I>.: Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica 89:832-836, 2004"},{"key":"5","unstructured":"5 Damaj G, Mohty M, Vey N, Dincan E, Bouabdallah R, <I>et al<\/I>.: Features of extramedullary and extraosseous multiple myeloma : a report of 19 patients from a single center. Eur J Haematol 73:402-406, 2004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Blad&eacute; J, Lust JA, Kyle RA: Immunoglobulin D multiple myeloma : presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 12:2398-2404, 1994","DOI":"10.1200\/JCO.1994.12.11.2398"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kneller A, Raanani P, Hardan I, Avigdor A, Levi I, <I>et al<\/I>.: Therapy with thalidomide in refractory multiple myeloma patients - The revival of an old drug. Br J Haematol 108:391-393, 2000","DOI":"10.1046\/j.1365-2141.2000.01835.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Yakoub-Agha I, Moreau P, Leyvraz S, Berthou C, Payen C, <I>et al<\/I>.: Thalidomide in patients with advanced multiple myeloma. Hematol J 1:186-189, 2000","DOI":"10.1038\/sj.thj.6200031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Nakazato T, Suzuki K, Mihara A, Sanada Y, Kakimoto T: Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion : remarkable response with a combination of thalidomide and dexamethasone. Intern Med 48:1827-1832, 2009","DOI":"10.2169\/internalmedicine.48.2142"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 91:4082-4085, 1994","DOI":"10.1073\/pnas.91.9.4082"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hideshima T, Anderson KC: Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer 2:927-937, 2002","DOI":"10.1038\/nrc952"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Moreira AL, Tsenova-Berkova L, Wang J, Laochumroonvorapong P, Freeman S, <I>et al<\/I>.: Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis 78:47-55, 1997","DOI":"10.1016\/S0962-8479(97)90015-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ye Q, Chen B, Tong Z, Nakamura S, Sarria R, <I>et al<\/I>.: Thalidomide reduces IL-18, IL-8 and TNF-_m461 release from alveolar macrophages in interstitial lung disease. Eur Respir J 28:824-831, 2006","DOI":"10.1183\/09031936.06.00131505"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Yasuda H, Ando J, Sato E, Inagaki N, Aritaka N, <I>et al<\/I>.: Successful treatment of extramedullary tumors with low-dose thalidomide in patients with multiple myeloma. Intern Med 49:2617-2620, 2010","DOI":"10.2169\/internalmedicine.49.4215"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kashyap R, Kumar R, Kumar S: Cranial nerve palsy in multiple myeloma and solitary plasmacytoma. Asia Pac J Clin Oncol 6:251-255, 2010","DOI":"10.1111\/j.1743-7563.2010.01327.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Dytfeld D, Matuszak M, Lewandowski K, Komarnicki M: Bortezomib in combination with thalidomide and dexamethasone -a successful treatment regimen in refractory extramedullary multiple myeloma. Ann Hematol 87:253-254, 2008","DOI":"10.1007\/s00277-007-0401-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Katodritou E, Speletas M, Pouli A, Tsitouridis J, Zervas K, <I>et al<\/I>.: Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone. Acta Haematol 117:20-23, 2007","DOI":"10.1159\/000096862"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Terrier B, Aouba A, Diop S, Clerc J, Vasiliu V, <I>et al<\/I>.: Thyroid gland plasmacytoma with a dramatic and persistent complete response under thalidomide and dexamethasone-associated treatment. Leuk Lymphoma 47:1424-1426, 2006","DOI":"10.1080\/10428190600585394"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Ribas C, Colleoni G, Almeida M, Duch CR, Ohashi C, <I>et al<\/I>.: Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma. Acta Oncol 43:215-216, 2004","DOI":"10.1080\/02841860310021536"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Gonz&aacute;lez-Porras JR, Gonz&aacute;lez M, Garcia-Sanz R, San Miguel JF: Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas. Br J Haematol 119:883-884, 2002","DOI":"10.1046\/j.1365-2141.2002.03870_8.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Biagi JJ, Mileshkin L, Grigg AP, Westerman DW, Prince HM: Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation. Bone Marrow Transplant 28:1145-1150, 2001","DOI":"10.1038\/sj.bmt.1703292"},{"key":"22","unstructured":"22 Wu KL, Helgason HH, van der Holt B, Wijermans PW, Lokhorst HM, <I>et al<\/I>.: Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma : response of soft-tissue plasmacytomas. Leukemia 19:143-145, 2005"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, <I>et al<\/I>.: Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma. Eur J Haematol 75:376-383, 2005","DOI":"10.1111\/j.1600-0609.2005.00531.x"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:32Z","timestamp":1621539992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/1\/53_21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.21","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}